What is the Projected CAGR value of the Classical Swine Fever Vaccines Market?
Classical Swine Fever Vaccines Market is expected to grow at a CAGR of 7.5% during the forecast period 2024-2031.
Which region controlled the global market during 2024-2031?
North America region Controls the Classical Swine Fever Vaccines Market during 2024-2031.
What are the vaccines available for classical swine fever?
There are a number of vaccines available to protect pigs against CSF. One of the most effective vaccines is Suvaxyn CSF Marker, which is a live attenuated vaccine that contains a modified bovine viral diarrhea virus (BVDV). BVDV is a closely related virus that is not harmful to pigs, but it can induce an immune response that protects against CSF.
Who are the key players in Classical Swine Fever Vaccines Market?
Major players are Panav Biotech, Boehringer Ingelheim International GmbH, Ceva, Bioveta, a.s., Indian Immunologicals Limited, and Qilu Animal Health Products Co., Ltd. among others.